Gastric cancer: surgery in 2011

Area of Science:

• Oncology
• Surgical Oncology
• Gastroenterology

Background:

• Gastric cancer treatment is increasingly individualized, considering prognostic factors, tumor location, and neoadjuvant treatment response.
• Endoscopic resections are suitable for early gastric cancer confined to the mucosa.
• Surgical strategies with lymphadenectomy are necessary for tumors invading the submucosa.

Purpose of the Study:

• To review current strategies for gastric cancer treatment, focusing on individualized approaches for early and advanced stages.
• To evaluate the role of neoadjuvant therapy and surgical techniques in improving patient outcomes.
• To highlight the importance of response prediction in multimodal treatment regimens.

Main Methods:

• Review of current literature and clinical guidelines on gastric cancer management.
• Analysis of data from randomized phase III studies on perioperative chemotherapy.
• Discussion of surgical techniques including laparoscopic approaches and lymphadenectomy modifications.

Main Results:

• Perioperative chemotherapy significantly improves survival for patients with locally advanced gastric cancer (Stage II/III).
• Laparoscopic resection can achieve excellent outcomes with experienced surgeons.
• Modified D2 lymphadenectomy without splenectomy is a standard procedure, improving prognosis in specific patient groups.

Conclusions:

• Individualized resection and lymphadenectomy techniques are crucial for early gastric cancer.
• Response-based neoadjuvant concepts are essential for locally advanced gastric cancer.
• Multimodal treatment, particularly perioperative chemotherapy, enhances survival compared to surgery alone.